IL1B and cancer: Cancer cell-derived DAMPs (danger-associated molecular patterns) [157], double-stranded oligodeoxynucleotides [158], or bacteria [159,160] can be used to activate TLRs and the inflammasome to enable DCs to release IL-1β.